BEBT-109, A PAN-MUTANT-SELECTIVE EGFR INHIBITOR WITH POTENT ANTITUMOR ACTIVITY IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER

BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancer

EGFR mutation-positive NSCLC tumors are highly heterogeneous, therefore, exploring an agent simultaneously targeting multiple EGFR mutations may be valuable for clinical practice.Compared with osimertinib, BEBT-109 shows more sensitive and extensive Toy Trucks antitumor activity in EGFR mutant NSCLC, while sparing wild-type EGFR cell lines.Meanwhil

read more



ANALISIS SENSORI RUSIP DARI SUNGAILIAT-BANGKA

The objective of this work was to analyze the sensory properties of rusip from traditional market in Sungailiat-Bangka.Purposed sampling was used to collect the samples, and sensory analysis was done by using free choice profiling (FCP) and focus groups method.The Results shows that sensory properties of raw rusip were opaq, thick, Natural Wall Dec

read more